Chemomab Therapeutics Ltd. (CMMB) — Institutional Holders, Q2 2026
13 institutional investment managers reported a CMMB position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $615.3K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
CMMB in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- CITADEL ADVISORSAdded · +31,129 sh+$50.4K
- Lido AdvisorsNew · +14,341 sh+$23.2K
- RHUMBLINE ADVISERSAdded · +12,163 sh+$19.7K
- Philadelphia Investment PartnersAdded · +6,800 sh+$11.0K
- SBI Securities , Ltd.Added · +6 sh+$10.00
Biggest sellers
- SmartHarvest PortfoliosSold out · -14,566 sh-$23.6K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPSold out · -13,491 sh-$21.9K
- GAMMA InvestingTrimmed · -2,839 sh-$4.6K
- XTX Topco LtdTrimmed · -2,642 sh-$4.3K
- BNP PARIBAS FINANCIAL MARKETSTrimmed · -1,620 sh-$2.6K
CMMB 13F holders ranked 1–13 of 13
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS#1 · 95,311 sh | 95,311 | $154.4K | 0.00% | +48.5% |
| 2 | ADAR1 Capital Management#2 · 80,000 sh | 80,000 | $129.6K | <0.01% | 0.0% |
| 3 | KESTRA PRIVATE WEALTH SERVICES#3 · 61,710 sh | 61,710 | $100.0K | <0.01% | 0.0% |
| 4 | Ikarian Capital#4 · 51,793 sh | 51,793 | $83.9K | <0.01% | 0.0% |
| 5 | RHUMBLINE ADVISERS#5 · 30,529 sh | 30,529 | $49.5K | 0.00% | +66.2% |
| 6 | XTX Topco Ltd#6 · 15,987 sh | 15,987 | $25.9K | <0.01% | -14.2% |
| 7 | Philadelphia Investment Partners#7 · 15,000 sh | 15,000 | $24.3K | 0.02% | +82.9% |
| 8 | Lido Advisors#8 · 14,341 sh | 14,341 | $23.2K | <0.01% | New |
| 9 | BNP PARIBAS FINANCIAL MARKETS#9 · 6,805 sh | 6,805 | $11.0K | 0.00% | -19.2% |
| 10 | GAMMA Investing#10 · 4,740 sh | 4,740 | $7.7K | — | -37.5% |
| 11 | MORGAN STANLEY#11 · 3,575 sh | 3,575 | $5.8K | 0.00% | -21.9% |
| 12 | SBI Securities , Ltd.#12 · 34 sh | 34 | $55.00 | — | +21.4% |
| 13 | Caitong International Asset Management , Ltd#13 · 8 sh | 8 | $13.00 | 0.00% | 0.0% |
Funds that sold out of CMMB in Q2 2026 (3)
Held CMMB at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| SmartHarvest Portfolios14,566 sh | 14,566 | $22.9K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP13,491 sh | 13,491 | $21.2K |
| UBS Group AG8 sh | 8 | $13.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.